​

Funding Round

Post-IPO Equity - Verona Pharma

Post-IPO Equity - Verona Pharma

Investment Firm

Overview

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

Announced Date

Jul 17, 2020

Funding Type

Post Ipo Equity

Highlights

Location

Europe

Social

Investor Lead

RA Capital Management

RA Capital Management

RA Capital Management is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

21

Investor Name
Participant InvestorNovo Holdings
Participant InvestorAisling Capital
Participant InvestorAcorn Bioventures
Participant InvestorVivo Capital
Participant InvestorNew Enterprise Associates

Round Details and Background

Verona Pharma raised $200000000 on 2020-07-17 in Post-IPO Equity

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 02, 2024
Post-IPO Debt - Verona Pharma
2-400.0M
May 09, 2024
Post-IPO Debt - Verona Pharma
2-650.0M
Jun 20, 2016
Post-IPO Equity - Verona Pharma
9-65.6M
Feb 06, 2012
Post-IPO Equity - Verona Pharma
1-11.5M

Recent Activity

There is no recent news or activity for this profile.